ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Rumors Preceded Broder’s Move

December 22, 1994

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

May 2, 2008

In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post

January 31, 1992

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

April 26, 1996